Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Novo Nordisk cuts Wegovy's price and commits fully to its upcoming weight-loss pill to stay competitive in the fast-growing ...

That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...

A recent trial revealed that a new daily weight-loss pill developed by the Eli Lilly has shown exceptional results in a ...

A once-a-day pill could offer “more access” to weight loss medication, experts have said after a new study confirmed the ...

A WEIGHT loss pill set to be available next year will be a cheaper, easier and effective alternative to Mounjaro injections, ...

The side effects seen includes nausea, vomiting, constipation and diarrhoea – particularly at higher doses. Read more at ...